GSTM1 and GSTT1 null polymorphisms and risk of salivary gland carcinoma

Authors

Sayaka Kondo, Departments of Head and Neck Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA; The University of Texas Dental Branch, Houston, Texas, USA
Erich M. Sturgis, Departments of Head and Neck Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA; Departments of Epidemiology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA
Fanglin Li, Departments of Head and Neck Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA; Department of Hematology, Qilu Hospital, Shandong University, Jinan, P.R. China, 250012
Qingyi Wei, Departments of Epidemiology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA
Guojun Li, Departments of Head and Neck Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA; Departments of Epidemiology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA

Publication Date

2-2009

Journal

Int J Clin Exp Med. 2009; 2(1): 68–75.

Abstract

Glutathione S-transferase (GST) genes detoxify and metabolize carcinogens, including oxygen free radicals which may contribute to salivary gland carcinogenesis. This cancer center-based case-control association study included 166 patients with incident salivary gland carcinoma (SGC) and 511 cancer-free controls. We performed multiplex polymerase chain reaction-based polymorphism genotyping assays for GSTM1 and GSTT1 null genotypes. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated with multivariable logistic regression analyses adjusted for age, sex, ethnicity, tobacco use, family history of cancer, alcohol use and radiation exposure. In our results, 27.7% of the SGC cases and 20.6% of the controls were null for the GSTT1 (P = 0.054), and 53.0% of the SGC cases and 50.9% of the controls were null for the GSTM1 (P = 0.633). The results of the adjusted multivariale regression analysis suggested that having GSTT1 null genotype was associated with a significantly increased risk for SGC (odds ratio 1.5, 95% confidence interval 1.0-2.3). Additionally, 13.9% of the SGC cases but only 8.4% of the controls were null for both genes and the results of the adjusted multivariable regression analysis suggested that having both null genotypes was significantly associated with an approximately 2-fold increased risk for SGC (odds ratio 1.9, 95% confidence interval 1.0-3.5). The presence of GSTT1 null genotype and the simultaneous presence of GSTM1 and GSTT1 null genotypes appear associated with significantly increased SGC risk. These findings warrant further study with larger sample sizes.

Keywords

Glutathione S-transferase (GST); single nucleotide polymorphism; salivary gland carcinoma (SGC); genetic susceptibility; molecular epidemiology

Comments

PMCID: PMC2680049

Recommended Citation

Kondo, Sayaka; Sturgis, Erich M.; Li, Fanglin; Wei, Qingyi; and Li, Guojun, "GSTM1 and GSTT1 null polymorphisms and risk of salivary gland carcinoma" (2009). Faculty, Staff and Student Publications. 12.
https://digitalcommons.library.tmc.edu/uthdb_docs/12